GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Cyclically Adjusted Revenue per Share

Celltrion (XKRX:068270) Cyclically Adjusted Revenue per Share : ₩9,949.94 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Celltrion Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Celltrion's adjusted revenue per share for the three months ended in Dec. 2023 was ₩2,684.443. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩9,949.94 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Celltrion's average Cyclically Adjusted Revenue Growth Rate was 19.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 21.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 22.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Celltrion was 24.00% per year. The lowest was 6.30% per year. And the median was 21.70% per year.

As of today (2024-04-27), Celltrion's current stock price is ₩176600.00. Celltrion's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₩9,949.94. Celltrion's Cyclically Adjusted PS Ratio of today is 17.75.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Celltrion was 94.33. The lowest was 14.12. And the median was 37.23.


Celltrion Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Celltrion's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Cyclically Adjusted Revenue per Share Chart

Celltrion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,373.99 5,519.92 6,818.33 8,347.09 9,949.94

Celltrion Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,347.09 8,772.97 9,131.82 9,705.66 9,949.94

Competitive Comparison of Celltrion's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Celltrion's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celltrion's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celltrion's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Celltrion's Cyclically Adjusted PS Ratio falls into.



Celltrion Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Celltrion's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2684.443/118.8477*118.8477
=2,684.443

Current CPI (Dec. 2023) = 118.8477.

Celltrion Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 610.598 99.253 731.143
201406 1,135.492 99.353 1,358.294
201409 736.842 99.608 879.166
201412 854.275 99.098 1,024.527
201503 690.423 99.720 822.856
201506 1,165.023 100.050 1,383.911
201509 1,059.206 100.110 1,257.459
201512 1,299.576 100.220 1,541.126
201603 720.602 100.560 851.650
201606 1,216.894 100.790 1,434.915
201609 1,105.526 101.460 1,294.985
201612 1,691.015 101.560 1,978.862
201703 1,325.177 102.850 1,531.300
201706 1,665.437 102.610 1,928.987
201709 1,568.098 103.490 1,800.800
201712 2,005.643 102.990 2,314.458
201803 1,647.952 104.100 1,881.415
201806 1,770.529 104.130 2,020.775
201809 1,558.618 105.650 1,753.319
201812 1,772.397 104.350 2,018.642
201903 1,453.013 104.490 1,652.668
201906 1,543.043 104.880 1,748.542
201909 1,896.773 105.200 2,142.843
201912 3,102.092 105.120 3,507.197
202003 2,518.608 105.540 2,836.183
202006 2,892.738 104.870 3,278.299
202009 3,693.415 106.200 4,133.276
202012 3,640.396 105.765 4,090.683
202103 3,075.802 107.357 3,405.007
202106 2,907.301 107.579 3,211.847
202109 2,708.004 108.759 2,959.198
202112 4,417.374 109.676 4,786.761
202203 3,535.344 111.806 3,758.012
202206 3,982.089 114.083 4,148.409
202209 4,323.909 114.831 4,475.144
202212 4,040.917 115.200 4,168.862
202303 4,174.711 116.550 4,257.027
202306 3,671.888 117.140 3,725.421
202309 4,731.449 119.111 4,720.982
202312 2,684.443 118.848 2,684.443

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Celltrion  (XKRX:068270) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Celltrion's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=176600.00/9949.94
=17.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Celltrion was 94.33. The lowest was 14.12. And the median was 37.23.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Celltrion Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Celltrion's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Celltrion (XKRX:068270) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion (XKRX:068270) Headlines

No Headlines